Spatiotemporal Associations Between the COVID-19 Pandemic and Cancer Diagnoses in Bavaria
NCT07008560 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 438000
Last updated 2026-01-06
Summary
The COVID-19 pandemic has placed a significant strain on healthcare systems worldwide and has also impacted the diagnosis and treatment of cancer. In Germany, there was a notable decline in cancer diagnoses during the pandemic, partly due to delays in early detection and limited access to medical treatments.
This study examines how the number of cancer cases in Bavaria changed before and during the pandemic, taking various factors into account, such as the socioeconomic status of different regions, the age of affected individuals, and the severity of the pandemic in each region.
We aim to determine whether certain regions or specific types of tumors experienced greater declines in diagnoses, particularly for cancers with regular screening programs. The study seeks to provide a better understanding of how different social and geographical conditions influenced cancer diagnoses during the pandemic. These insights could help improve future preparedness for health crises like the pandemic and ensure that cancer treatment continues to function effectively even in times of crisis.
Conditions
Sponsors & Collaborators
-
Ludwig-Maximilians - University of Munich
collaborator OTHER -
Bavarian Cancer Registry
lead OTHER_GOV
Principal Investigators
-
Jacqueline Müller-Nordhorn, Prof. Dr. · Bavarian Cancer Registry, Bavarian Health and Food Safety Authority
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-03
- Primary Completion
- 2025-12-31
- Completion
- 2026-02-28
Countries
- Germany
Study Locations
More Related Trials
-
A Study of Risk Factors for the COVID-19 Virus Infection
NCT04697927 ·Status: ACTIVE_NOT_RECRUITING
-
COVID-19 Infection Screening in Cancer Patients (NEOSCREENCOVID)
NCT04492410 ·Status: COMPLETED ·Phase: NA
-
Real-time Monitoring of Concentration and Size Variations of Circulating Plasma Free DNA to Predict Early Response to Immunotherapies in Patients With Different Types of Cancer.
NCT05083494 ·Status: UNKNOWN
-
Liquid Biopsy of Head and Neck Cancer Patients in Blood and Saliva
NCT05122507 ·Status: UNKNOWN
-
New Serum Biomarkers for Monitoring Early Diagnosis of Ovarian Cancer Recurrence
NCT05410028 ·Status: RECRUITING
-
Study of the Effect of SNPs in p53 and p53 Response Elements on the Inflammatory Response to DNA Damage
NCT01143519 ·Status: COMPLETED
-
Cancer: Rapid Diagnostics and Immune Assessment for SARS-CoV-2 (COVID-19)
NCT04427280 ·Status: COMPLETED
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma
NCT04490564 ·Status: COMPLETED
-
Study on Infectious Mononucleosis in Munich
NCT06002802 ·Status: COMPLETED
-
Procalcitonin as a Marker of Infection in Cancer Patients
NCT01227109 ·Status: UNKNOWN
-
Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Cancer
NCT00001163 ·Status: ACTIVE_NOT_RECRUITING
-
Pancreatic Cancer Genetics
NCT01102569 ·Status: RECRUITING
-
Liquid Biopsy for ctDNA in Peritoneal Lavage and Blood in Pancreatic Cancer
NCT05400681 ·Status: UNKNOWN
-
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
NCT04865133 ·Status: COMPLETED
-
Tumor Molecular Profiling in Patients With Prostate Cancer
NCT05573789 ·Status: COMPLETED
-
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250 ·Status: COMPLETED
-
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Melanoma
NCT03727087 ·Status: TERMINATED
-
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
NCT05604573 ·Status: UNKNOWN
-
Early Detection of Ovarian Cancer Using Plasma Cell-free DNA Fragmentomics (Retrospective Study)
NCT05693974 ·Status: UNKNOWN
-
Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer
NCT03622385 ·Status: COMPLETED
-
Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.
NCT05458973 ·Status: UNKNOWN
-
Characterization of Human Cancers by Molecular Profiling of Patient Biospecimens
NCT02749838 ·Status: UNKNOWN
-
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT05366881 ·Status: RECRUITING
-
Biopsies of Cancer Patients for Tumor Molecular Characterization
NCT01061944 ·Status: COMPLETED
-
Study of the Specific Seroprevalence of SARS-CoV-2 in a Sample of Patients and Salaried Staff From a French Anti-cancer Center at the End of the Containment Period of the SARS-CoV-2 Pandemic
NCT04517097 ·Status: COMPLETED